J. I. Epstein

发表

ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program.

A. Partin, L. Sokoll, J. Epstein, 2011, Urology.

Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.

D. Chan, P. Walsh, L. Sokoll, 1998, The Journal of urology.

Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.

P. Walsh, J. Epstein, H. Carter, 1997, The Journal of urology.

Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis.

J. Epstein, Misop Han, H. Carter, 2013, The Journal of urology.

Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.

A W Partin, A. Partin, P. Walsh, 1993, The Urologic clinics of North America.

Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.

A W Partin, A. Partin, P. Walsh, 1993, The Journal of urology.

Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer.

K. Fischbeck, P. Walsh, W. Isaacs, 1994, Biochemical and biophysical research communications.

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.

A. Kibel, M. Roobol, M. Emberton, 2013, European urology.

Importance of posterolateral needle biopsies in the detection of prostate cancer.

P. Walsh, J. Epstein, H. Carter, 2001, Urology.

Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.

P. Walsh, J. Epstein, H. Carter, 1997, The Journal of urology.

Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.

A. Partin, A. Billis, P. Landis, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies.

J. Epstein, S. Potter, Jonathan I. Epstein, 2001, The Journal of urology.

Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory.

J. Epstein, G. Dasilva, H. Kahane, 1995, Urology.

Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).

P. Walsh, J. Epstein, C. Brendler, 1994, The Journal of urology.

Is submission of remaining tissue necessary when incidental carcinoma of the prostate is found on transurethral resection?

J. Epstein, P. McDowell, W. Fox, 1994, Human pathology.

Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer.

J. Oesterling, P. Walsh, J. Epstein, 1988, The Journal of urology.

Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.

J. Oesterling, P. Walsh, J. Epstein, 1987, The Journal of urology.

Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.

A. Partin, P. Walsh, J. Epstein, 1989, The Journal of urology.

The inability of adrenal androgens to stimulate the adult human prostate: an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism.

J. Oesterling, P. Walsh, J. Epstein, 1986, The Journal of urology.

Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy.

P. Walsh, J. Epstein, G. Steinberg, 1994, The Journal of urology.

Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging.

C. Tempany, A. Rahmouni, E. Zerhouni, 1991, Radiology.

Radical retropubic prostatectomy. How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle?

T. Tsuzuki, B. Trock, P. Walsh, 2005, The Journal of urology.

Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression?

J. Epstein, J. Sauvageot, Jurga Sauvageot, 1997, The Journal of urology.

Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?

J. Epstein, D. Chan, T. Chan, 2001, The Journal of urology.

Adenocarcinoma of the prostate in men younger than 40 years of age: diagnosis and treatment with emphasis on radical prostatectomy findings.

A. Partin, J. Epstein, H. Kahane, 1999, Urology.

Radical prostatectomy in men less than 50 years old.

A. Partin, P. Walsh, J. Epstein, 1995, Urologic oncology.

Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease.

A. Partin, J. Epstein, H. Carter, 1999, Urology.

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.

F. Marshall, A. Partin, P. Walsh, 1995, Urology.

Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.

A. Partin, P. Landis, Zhaoyong Feng, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens.

J. Oesterling, P. Walsh, J. Epstein, 1986, The Journal of urology.

Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters.

A. Partin, P. Walsh, J. Epstein, 2000, Urology.

Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle.

Patrick C. Walsh, J. I. Epstein, Franklin C. Lowe, 1987, The Journal of urology.

Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy.

C. Pound, Patrick C. Walsh, J. I. Epstein, 1999, Urology.

A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis.

A W Partin, A. Partin, D. S. Coffey, 1989, The Journal of urology.

Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma.

C. Pan, J. Epstein, A. E. Sehdev, 2001, Human pathology.

Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.

P. Walsh, J. Epstein, H. Carter, 1997, Journal of Urology.

Biopsy criteria for determining appropriateness for active surveillance in the modern era.

B. Trock, J. Epstein, H. Carter, 2014, Urology.

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.

P. Walsh, J. Epstein, H. Carter, 2002, The Journal of urology.

Evaluation of apparent diffusion coefficient as a predictor of grade reclassification in men on active surveillance for prostate cancer.

K. Macura, J. Epstein, H. Carter, 2020, Urology.

Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.

D. Sundi, Oleksandr N. Kryvenko, Jonathan I. Epstein, 2014, The Journal of urology.

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.

B. Trock, A. Partin, R. Veltri, 2012, The Journal of urology.

Longitudinal Assessment of Urinary PCA3 for Predicting Prostate Cancer Grade Reclassification in Favorable Risk Men during Active Surveillance

Jonathan I. Epstein, Mufaddal Mamawala, L. Sokoll, 2017, Prostate Cancer and Prostatic Diseases.

Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer.

D. Chan, A. Partin, P. Walsh, 2001, Urology.

Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification.

B. Trock, K. Macura, M. Mamawala, 2023, Urologic oncology.

PSA and PAP as immunohistochemical markers in prostate cancer.

J. Epstein, J. I. Epstein, 1993, The Urologic clinics of North America.

Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis.

S. Snyder, D. Bredt, C. Lowenstein, 1993, The Journal of urology.